Z Fin (1168 HK): Synthetic Expert Call Transcript (14 Oct 2026)
The proposed HK$6.60 privatization offer severely undervalues Z Fin's core operations, effectively assigning a zero to negative implied valuation...
7 Views
Akeso (9926 HK): Synthetic Expert Call Transcript (14 Oct 2026)
Ivonescimab’s head-to-head overall survival (OS) victory over Keytruda in HARMONi-2 (median OS 30.8 months vs 22.6 months, HR 0.73) validates the...
10 Views
Quiddity Leaderboard CSI Medical Dec26: Expectations Have Changed; US$301mn One-Way
There are three index members failing the liquidity test by narrow margins and they should be monitored until the end of the reference period.
27 Views
Quiddity Leaderboard ChiNext & ChiNext 50 Dec26: Expected ADDs Sharply Down Vs Expected DELs
We see US$373mn and US220mn one-way flows for ChiNext and ChiNext 50 respectively. ChiNext expectations are mostly final but ChiNext 50...
31 Views
HK IPO Cornerstone Performance League Table (9M2026)
HK IPO: We rank repeat cornerstone investors by the average 2W return of IPOs they backed. In 9M2026, deals with hedge fund cornerstones...
43 Views